Academic Urology Unit

Medicine & Life Sciences

1. Systematic Reviews 100%
2. Urology 69%
3. Prostatic Neoplasms 53%
4. Randomized Controlled Trials 40%
5. Guidelines 38%
6. Urinary Bladder Neoplasms 31%
7. Urinary Incontinence 31%
8. Meta-Analysis 28%
9. Stress Urinary Incontinence 28%
10. Cost-Benefit Analysis 27%
11. Transurethral Resection of Prostate 23%
12. Suburethral Slings 22%
13. Lower Urinary Tract Symptoms 22%
14. Therapeutics 21%
15. Practice Guidelines 19%
16. Quality of Life 18%
17. Renal Cell Carcinoma 18%
18. Prostate 17%
19. Lithotripsy 15%
20. Pelvic Floor 15%
21. Confidence Intervals 15%
22. Costs and Cost Analysis 14%
23. Urinary Bladder 13%
24. Patient Reported Outcome Measures 13%
25. Urodynamics 12%
26. Delivery of Health Care 12%
27. Urinary Tract Infections 10%
28. Neoplasms 10%
29. Ureteroscopy 10%
30. Odds Ratio 10%
31. MEDLINE 10%
32. Consensus 10%
33. Kidney Neoplasms 9%
34. Recurrence 9%
35. Catheters 9%
36. Quality-Adjusted Life Years 9%
37. Catheterization 9%
38. Urinary Catheters 9%
39. Muscles 9%
40. Overactive Urinary Bladder 9%
41. Prostatectomy 9%
42. Conservative Treatment 9%
43. Placebos 8%
44. Economics 8%
45. Cystectomy 8%
46. Congresses 8%
47. Urologic Neoplasms 8%
48. Prostatic Hyperplasia 8%
49. Tamsulosin 8%
50. Biopsy 7%
51. Urinary Bladder Neck Obstruction 7%
52. Health 7%
53. Lymph Node Excision 7%
54. Education 7%
55. Prospective Studies 7%
56. Big Data 7%
57. Uncertainty 7%
58. Urinary Diversion 7%
59. Patient Participation 6%
60. Nephrectomy 6%
61. Intravesical Administration 6%
62. Watchful Waiting 6%
63. Guideline Adherence 6%
64. Kidney 6%
65. Antibiotic Prophylaxis 6%
66. Urethral Stricture 6%
67. Decision Making 6%
68. Prostate-Specific Antigen 6%
69. Urologists 5%
70. Indwelling Catheters 5%
71. Percutaneous Nephrolithotomy 5%
72. Electric Stimulation 5%
73. Equivalence Trials 5%
74. Equipment and Supplies 5%
75. Observational Studies 5%
76. Nuclear Medicine 5%
77. Databases 5%
78. Social Media 5%
79. Risk Assessment 5%
80. Urinary Retention 5%
81. Reproductive Health 5%
82. Cystoscopy 5%
83. Sexual Health 5%
84. Random Allocation 5%
85. Molecular Imaging 5%
86. Conflict of Interest 5%
87. Chronic Kidney Failure 5%